Bigger, faster?: Associations between hospital thrombolysis volume and speed of thrombolysis administration in acute ischemic stroke

Stroke

Volumn 44, Issue 11, 2013, Pages 3129-3135

  Bray, Benjamin D ^a   Campbell, James ^b   Cloud, Geoffrey C ^c   Hoffman, Alex ^b   Tyrrell, Pippa J ^d   Wolfe, Charles D A ^a,e   Rudd, Anthony G ^a,e  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ROYAL COLLEGE OF PHYSICIANS   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

High volume; Hospitals; Stroke; Thrombolytic therapy

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; BRAIN SCINTISCANNING; DISEASE ASSOCIATION; HIGH VOLUME HOSPITAL; HOSPITAL; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UNITED KINGDOM;

HOSPITALS, HIGH-VOLUME; STROKE; THROMBOLYTIC THERAPY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; FIBRINOLYTIC AGENTS; HOSPITALS; HOSPITALS, HIGH-VOLUME; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TIME-TO-TREATMENT; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84888301445     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.001981     Document Type: Article

References (23)

1. Wardlaw JM, Murray V, Berge E, Del Zoppo G, Sandercock P, Lindley RL, et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012;379:2364-2372.
2. Marler JR, Tilley BC, Lu M, Brott TG, Lyden PC, Grotta JC, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology. 2000;55:1649-1655.
3. Jauch EC, Saver JL, Adams HP, Bruno A, Connors JJ, Demaerschalk BM et al. Guidelines for the early management of adults with acute ischaemic stroke (AHA/ASA Guideline). Stroke. 2013;44:870-947.
4. Intercollegiate Stroke Working Party. National Clinical Guideline for Stroke. 4th ed. London, UK: Royal College of Physicians; 2012.
5. Evenson KR, Foraker RE, Morris DL, Rosamond WD. A comprehensive review of prehospital and in-hospital delay times in acute stroke care. Int J Stroke. 2009;4:187-199.
6. McNeill L, English SW, Borg N, Matta BF, Menon DK. Effects of institutional caseload of subarachnoid hemorrhage on mortality: a secondary analysis of administrative data. Stroke. 2013;44:647-652.
7. Ross JS, Normand SL, Wang Y, Ko DT, Chen J, Drye EE, et al. Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med. 2010;362:1110-1118.
8. Shahin J, Harrison DA, Rowan KM. Relation between volume and outcome for patients with severe sepsis in United Kingdom: retrospective cohort study. BMJ. 2012;344:e3394.
9. Royal College of Physicians. Stroke Improvement National Audit Programme. http://www.rcplondon. ac.uk/projects/stroke-improvementnational-audit- programme-sinap. Accessed April 25, 2013.
10. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
11. Ordnance Survey OpenData. http://www.ordnancesurvey.co.uk/oswebsite/ products/os-opendata.html. Accessed April 25, 2013.
12. Royal College of Physicians. Sentinel Stroke Audit Programme. http://www.rcplondon. ac.uk/resources/national-sentinel-stroke-audit. Accessed April 25, 2013.
13. Hintze JL, Nelson RD. Violin plots: a box plot-density trace synergism. Am Stat. 1998;52:181-184.
14. Hacke W, Donnan G, Fieschi C, Kaste M, Von Kummer R, Broderick J P, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
15. Ahmed N, Wahlgren N, Grond M, Hennerici M, Lees KR, Mikulik R et al. Implementation and outcome of thrombolysis with alteplase 3-4. 5 h after an acute stroke: an updated analysis from SITS0-ISTR. Lancet Neurol. 2010;9:866-874.
16. Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, et al. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis. Cerebrovasc Dis. 2007;24:56-65.
17. Kim SK, Lee SY, Bae HJ, Lee YS, Kim SY, Kang MJ, et al. Pre-hospital notification reduced the door-to-needle time for iv t-PA in acute ischaemic stroke. Eur J Neurol. 2009;16:1331-1335.
18. Lindsberg PJ, Häppölä O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology. 2006;67:334-336.
19. Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffman C, Adelmann M. Frequency of thrombolytic therapy in patients with acute ischaemic stroke and the risk of in-hopsital mortality: the German Stroke Registers Study Group. Stroke. 2003;34:1106-1112.
20. Halm EA, Lee C, Chassin MR. Is volume related to outcome in health care? A systematic review and methodologic critique of the literature. Ann Intern Med. 2002;137:511-520.
21. Fonarow GC, Smith EE, Saver JL, Reeves MJ, Bhatt DL, Grau-Sepulveda M V, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation. 2011;123:750-758.
22. Mikulik R, Kadlecova P, Czlonkowska A, Kobayashi A, Brozman M, Svigelj V. Factors influencing in-hospital delays in treatment with intravenous thrombolysis. Stroke. 2012;43:1578-1583.
23. Hunter RM, Davie C, Rudd A, Thompson A, Walker H, Thomson N, et al. Impact on clinical and cost outcomes of a centralized approach to acute stroke care in London: a comparative effectiveness before and after model. PLoS One. 2013;8:e70420.